Loading...

1CM Inc.

EPIC.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.14
$-0.01(-3.57%)
Canadian Market opens in NaNh NaNm

1CM Inc. (EPIC.CN) Stock Competitors & Peer Comparison

See (EPIC.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
EPIC.CNCA$0.14-3.57%15.9M6.75CA$0.02N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
CURA.TOCA$4.17+0.24%3.2B-9.48-CA$0.44N/A
BHC.TOCA$7.83-3.09%2.9B13.50CA$0.58N/A
GTII.CNCA$9.70-0.92%2.2B14.70CA$0.66N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
TRUL.CNCA$9.54-0.42%1.6B-11.92-CA$0.80N/A
CRON.TOCA$3.75-0.79%1.4B-125.00-CA$0.03N/A
TLRY.TOCA$9.44-3.18%1.1B-0.47-CA$20.09N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

EPIC.CN vs CURA.CN Comparison April 2026

EPIC.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EPIC.CN stands at 15.9M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, EPIC.CN is priced at CA$0.14, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EPIC.CN currently has a P/E ratio of 6.75, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, EPIC.CN's ROE is +0.02%, compared to CURA.CN's ROE of -0.24%. Regarding short-term risk, EPIC.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for EPIC.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions